Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Project Description:
Datamonitors' Altor BioScience Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Altor BioScience Corp. since January 2007.
Scope:
– Provides intelligence on Altor BioScience Corp.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by Altor BioScience Corp. and its subsidiaries since 2007. – Information about key financial and legal advisors for Altor BioScience Corp.'s financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Highlights:
This report includes Altor BioScience Corp.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Altor BioScience Corp.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about Altor BioScience Corp.’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
Regenerative Medicine Market Research Report by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule and Biologic, and Tissue-Engineered Products), by Application (Diabetes, Musculoskeletal Disorders, Ocular Disorders, Oncology, and Wound Care) - Global Forecast to 2025 - Cumulative Impact of...
Biomedical Microelectromechanical Systems Market Research Report by Type (In Vivo Devices and Microcantilever Sensors), by Application (Analysis, Cell Culture, Detection, Diagnostic, and Drug Delivery) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and...
Cell Sorting Market Research Report by Technology (Fluorescence-Based Droplet Cell Sorting, Magnetic-Activated Cell Sorting (MACS), and Micro-Electromechanical System (MEMS)), by Offering (Cell Sorters, Cell Sorting Reagents & Consumables, and Cell Sorting Services), by Application, by End User - Global Forecast to 2025 - Cumulative...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the cell and gene therapy market are Gilead Sciences, Bristol-Myers Squibb, Novartis AG, Amgen, Merck, Organogenesis Holdings, Dendreon, Vericel, Bluebird Bio and Fibrocell Science. The global cell and gene therapy market is expected to decline from $6.68 billion in 2019 to $6.92 billion in 2020 at a compound annual...
2020-2025 US Tumor Marker Testing Database: Supplier Shares, Volume and Sales Segment Forecasts for Major Cancer Diagnostic Tests This database provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for major tumor markers, as well as comprehensive lists of companies developing or marketing new...
“TOCILIZUMAB- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Adult-onset Still’s Disease in 7 Major Markets. A detailed picture of the TOCILIZUMAB in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...
Immunosuppressant Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Immunosuppressant Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunosuppressant Therapeutic...
2021 Japan Cancer Diagnostics Market Assessment--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report is a study of the major business opportunities emerging in the...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.